Phase II Study of ASP0456 - A Double-blind, Placebo-controlled, Parallel-group, Comparative Study in Patients With Chronic Constipation (Not Including Constipation Due to Organic Diseases)

Trial Profile

Phase II Study of ASP0456 - A Double-blind, Placebo-controlled, Parallel-group, Comparative Study in Patients With Chronic Constipation (Not Including Constipation Due to Organic Diseases)

Completed
Phase of Trial: Phase II

Latest Information Update: 09 May 2017

At a glance

  • Drugs Linaclotide (Primary)
  • Indications Constipation
  • Focus Therapeutic Use
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 09 May 2017 Primary endpoint (Change in weekly average of SBM frequency) has been met as per the results presented at the Digestive Disease Week 2017
    • 09 May 2017 Results presented at the Digestive Disease Week 2017
    • 01 May 2017 According to an Ironwood Pharmaceuticals media release, data from this trial will be presented at the Digestive Disease Week 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top